Nelda J. Connors - 02 Aug 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: Director
Signature: /s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 02 Aug 2022
Net transactions value: -$668,939
Form type: 4
Filing time: 04 Aug 2022, 17:01:14 UTC
Previous filing: 18 May 2022
Next filing: 31 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Sale	$668,939	-16,088	-77%	$41.58	4,877	02 Aug 2022	Direct	F1, F2
holding	BSX	Common Stock						45,442	02 Aug 2022	By Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $41.575 to $41.595, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2	The most recently filed Form 4 reported 15,965 shares directly beneficially owned by the reporting person and 50,442 shares held by the Nelda J. Connors Trust, for which the reporting person is the sole trustee. 4,990 of the shares previously reported as being directly beneficially owned were in fact held indirectly, by the Nelda J. Connors Trust. A subsequent share transfer of 9,990 shares from the Nelda J. Connors Trust to the reporting person to be held directly was initiated to facilitate the sales reported on this Form 4.

Content

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $41.575 to $41.595, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The most recently filed Form 4 reported 15,965 shares directly beneficially owned by the reporting person and 50,442 shares held by the Nelda J. Connors Trust, for which the reporting person is the sole trustee. 4,990 of the shares previously reported as being directly beneficially owned were in fact held indirectly, by the Nelda J. Connors Trust. A subsequent share transfer of 9,990 shares from the Nelda J. Connors Trust to the reporting person to be held directly was initiated to facilitate the sales reported on this Form 4.